Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRS3 | P32247 | 7/20 | 0.47 |
| ▸ | DHODH | Q02127 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.39 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9510826 | 0.90 | BRS3 (0.55) | BRS3AGTR1AGTR2 | |
| SCHEMBL9452730 | 0.86 | BRS3 (0.57) | BRS3AGTR1AGTR2 | |
| SCHEMBL8741191 | 0.84 | BRS3 (0.47) | BRS3DHODHFOLH1AGTR1AGTR2 | |
| SCHEMBL9304542 | 0.76 | BRS3 (0.56) | BRS3AGTR1AGTR2 | |
| SCHEMBL9452733 | 0.75 | BRS3 (0.56) | BRS3AGTR1AGTR2 | |
| SCHEMBL9202144 | 0.74 | AGTR1 (0.46) | BRS3DHODHFOLH1AGTR1AGTR2 | |
| SCHEMBL3737185 | 0.73 | FOLH1 (0.63) | BRS3DHODHFOLH1AGTR1AGTR2 | |
| SCHEMBL9529409 | 0.73 | BRS3 (0.55) | BRS3AGTR1AGTR2 | |
| SCHEMBL8504803 | 0.71 | DHODH (0.51) | BRS3DHODHFOLH1AGTR1AGTR2 | |
| SCHEMBL9200610 | 0.70 | BRS3 (0.42) | BRS3AGTR1AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0561979-A1 | USE OF ANGIOTENSIN II ANTAGONISTS IN THE TREATMENT OF ANGINA PECTORIS | SMITHKLINE BEECHAM PLC (GB) | 1993-09-29 | — | — | EP | disclosed |
| EP-0561905-A1 | USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF MACULAR DEGENERATION | SMITHKLINE BEECHAM PLC (GB) | 1993-09-29 | — | — | EP | disclosed |